Auteur J. F. DILLON

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience

S. J. HUTCHINSON ; J. F. DILLON ; R. FOX ; S. A. McDONALD ; H. A. INNES ; A. WEIR ; A. McLEOD ; E. J. ASPINALL ; N. E. PALMATEER ; A. TAYLOR ; A. MUNRO ; H. VALERIO ; G. BROWN ; D. J. GOLDBERG | 2015
Dans International Journal of Drug Policy (Vol.26, n°11, November 2015) Article : Périodique

Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan – a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure [...]

Plus d'info

Ajouter à la sélection

Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review

M. CAVEN ; A. MALAGUTI ; E. ROBINSON ; E. FLETCHER ; J. F. DILLON | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : Périodique

Background: A systematic review was conducted to determine the impact of Hepatitis C (HCV) treatment on substance use behaviour in people who inject drugs (PWID). Methods: A search for peer reviewed journal articles from 1991 to present day was[...]

Plus d'info

Ajouter à la sélection

Nouveauté

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]

J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]

Plus d'info

Ajouter à la sélection

Urgent action to fight hepatitis C in people who inject drugs in Europe

J. F. DILLON ; J. V. LAZARUS ; H. A. RAZAVI | 2016
Dans Hepatology, Medicine and Policy (Vol.1, n°2, 2016) Article : Périodique

Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and liver cancer, is curable in most people. Injecting drug use currently accounts for 80 % of new HCV infections with a known transmission route in the European Union (EU).[...]

Plus d'info

Ajouter à la sélection

Lien externe